Download PDF
Pharmacopsychiatry 2020; 53(04): 153-154
DOI: 10.1055/a-1212-1101
Editorial

Pharmacogenetics in Psychiatry

Daniel J. Müller
1   Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
2   Department of Psychiatry, University of Toronto, Toronto, ON, Canada
3   Department of Pharmacology, University of Toronto, Toronto, ON, Canada
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

This Special Issue on Pharmacogenetics in Psychiatry consists of five selected articles which encompass the first concepts of pharmacogenetics, to implementation strategies applyng pharmacogenetic testing into psychiatric clinical practice.



Publication History

Received: 11 May 2020
Received: 01 July 2020

Accepted: 02 July 2020

Article published online:
27 July 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Müller DJ, Rizhanovsky Z. From the Origins of Pharmacogenetics to First Applications in Psychiatry. Pharmacopsychiatry 2020; 53: 155–161
    PubMed
  • 2 Brown L, Eum S, Haga SB et al. Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. Pharmacopsychiatry 2020; 53: 162–173
    PubMed
  • 3 Fan M, Bousman CA. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines? Pharmacopsychiatry 2020; 53: 174–178
    PubMed
  • 4 Menke A, Weber H, Deckert J. Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital. Pharmacopsychiatry 2020; 53: 179–183
    PubMed
  • 5 Bättig VAD, Roll SC, Hahn M. Pharmacogenetic Testing in Depressed Patients and Interdisciplinary Exchange between a Pharmacist and Psychiatrists Results in Reduced Hospitalization Times. Pharmacopsychiatry 2020; 53: 185–192
    PubMed